Seven names based outside the U.S. made the IBD Global Leaders screen. Topping the list was Tencent Music Entertainment and Ireland-based Trane Technologies. Tencent stock and IBD 50 name Trane Technologies are both in or near buy zones.
Trane Technologies stock hit an all-time high Monday, while Tencent showed a 0.4% gain.
Tencent Stock Tops A Buy Zone
The IBD MarketSurge Growth 250 name soared around 15.6% in heavy volume Wednesday following the company's better-than-expected first-quarter earnings and revenue.
Shares broke out of a deep, 51-week-long consolidation pattern with a 15.77 buy point Wednesday, and are trading just above the top of the 5% buy zone, reaching 16.56.
Tencent's profit grew 24.6%, including a $327 million gain from the disposal of an investment. Its monthly active users dropped 4% while online music paying users increased 8.3% in Q1.
Tencent's quarterly estimates show an average 11% sales growth over the next four quarters.
Analysts recently raised full-year 2025 profit forecasts to reflect 30% growth, with 2026 estimates easing 2%.
Its Relative Strength Rating jumped to 94 from 87 a week ago. Shares have gained around 47% so far this year. Tencent stock is at a level not seen since May 2021.
Moreover, its relative strength line is nearing its 52-week high.
Tencent operates the leading online music entertainment platform in China from four music mobile apps.
Check Out The IBD Stock Of The Day
Trane Technologies Stock Hits New High
Trane Technologies stock broke out of an early-stage skewed cup base with a 422 buy point last week. Shares are in the buy range up to 443.10.
Its 50-day moving average is rising as it works its way up toward the 200-day moving average.
Its Relative Strength Rating jumped to 90 from 52 four weeks ago.
Trane handily beat first-quarter profit and sales estimates April 30. Earnings rose 26% to $2.45 per share on 11% sales growth.
It also reaffirmed its full-year 2025 earnings-per-share guidance of $12.70 to $12.90, and forecast 2025 revenue growth in the 7.5% to 8.5% range. Trane Technologies expects to be in the high end of both ranges.
The company has been a steady profit grower as seen in its Earnings Stability factor of 4 out of 99 possible — with a lower number being better.
Its 1.3 up/down volume ratio shows positive demand over the last 50 days and its Accumulation/Distribution Rating of B indicates moderate institutional buying over the last 13 weeks.
Mutual funds have added Trane stock for eight straight quarters, according to IBD Stock Checkup. Four IBD Mutual Fund Index names hold Trane stock, including Fidelity Contrafund and JPMorgan Large Cap Growth Fund, though both reduced their positions in the March quarter.
Trane makes air conditioning and heating systems for residential and commercial customers worldwide. Its Thermo King business provides environmentally friendly climate-controlled solutions to move refrigerated food, medicines and other perishables.
Follow Kimberley Koenig for more stock market news on X, the platform formerly known as Twitter, @IBD_KKoenig.
